NPM1 gene mutations account for ∼30% of adult AML lesions, and the majority of mutations, ∼50 different types, concern exon 12, specifically 14 distinct mutations include the most common, types A–F, and the other 8 mutations, named J–Q7. This evidence concerns the gene NPM1 and acute myeloid leukemia.